The FDA has recently blocked the publication of several studies that supported the safety of Covid-19 and shingles vaccines, a spokesperson for the Department of Health and Human Services (HHS) confirmed on Tuesday. This move is the latest in a series of actions under the Trump administration that challenge the accessibility and trust in vaccines.
Controversy Around Vaccine Safety Research
FDA scientists had worked with data firms to analyze millions of patient records for studies examining the side effects of the Covid-19 and Shingrix vaccines. The studies found that the side effects of these vaccines were rare, contradicting some of the public’s vaccine safety concerns.
However, in October, the FDA directed scientists to withdraw two Covid-19 vaccine studies that had been accepted for publication in medical journals. Additionally, in February, FDA officials did not approve the submission of abstracts regarding Shingrix, a shingles vaccine, to a drug safety conference.
Health and Human Services Spokesperson’s Statement
An HHS spokesperson explained that the studies were withdrawn because the authors “drew broad conclusions that were not supported by the underlying data”. The spokesperson added that the FDA acted to protect the integrity of the scientific process and ensure that all studies associated with the agency met “high standards”.
Regarding the Shingrix study, the spokesperson stated that the study design “fell outside the agency’s purview”, suggesting that it did not align with the FDA’s guidelines for such research.
Shift in Vaccine Policy Under Robert F. Kennedy Jr.
This action is part of a broader trend under Health and Human Services Secretary Robert F. Kennedy Jr., a prominent vaccine skeptic. Since taking office, Kennedy has overseen efforts to soften Covid-19 vaccine recommendations, reduce vaccine development research, and revamp the childhood immunization schedule.
These efforts, critics argue, make it harder for some patients to access vaccines and can undermine public confidence in vaccine safety.
The blocking of these studies adds fuel to ongoing debates over vaccine safety and the role of federal agencies in regulating and promoting immunization programs. The developments have drawn criticism from public health experts who argue that transparency and clear scientific communication are essential in combating vaccine misinformation.
